---
title: "重慶山外山血液淨化技術股份有限公司 (688410.SH)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/688410.SH.md"
symbol: "688410.SH"
name: "重慶山外山血液淨化技術股份有限公司"
industry: "醫療器械"
---

# 重慶山外山血液淨化技術股份有限公司 (688410.SH)

| Item | Detail |
|------|--------|
| Industry | 醫療器械 |
| Location | 滬深市場 |
| Website | [www.swskj.com](https://www.swskj.com) |

## Company Profile

公司成立于 2001 年，為全球腎臟病和危重症患者提供血液淨化整體解決方案。公司是中國血液淨化行業的龍頭企業、國家標準和行業標準起草單位。公司產品已銷往國內外數千家醫療機構，包括解放軍總醫院、上海交通大學附屬醫院、南方醫科大學附屬珠江醫院、山東大學齊魯醫院、中南大學湘雅二院等多家知名大型三甲醫院，並出口意大利、希臘、西班牙、馬來西亞、印度、南非等全球 100 多個國家和地區，實現市場裝機數萬台，服務全球數十萬名腎病患者。公司是專業從事血液淨化設備與耗材的研發、生產和銷售，並提供連鎖血液透析醫療服務的國家高新技術企業。公司主要產品有血液灌流機、連續性血液淨化設備、血液透析機、血液淨化設備、血液透...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-19T04:30:10.000Z

**Overall: B (0.31)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 19 / 63 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 37.78% |  |
| Net Profit YoY | 51.60% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 3.14 |  |
| Dividend Ratio | 0.58% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 5.52B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 733.60M |  |


**Multi Score**: B

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 6.55% | C |
| Profit Margin | 15.46% | A |
| Gross Margin | 50.86% | B |

#### Growth Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 37.78% | A |
| Net Profit YoY | 51.60% | B |
| Total Assets YoY | 12.70% | B |
| Net Assets YoY | 4.41% | C |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 646.73% | C |
| OCF YoY | 37.78% | A |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.36 | C |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 18.91% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 重慶山外山血液淨化技術股份有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "6.55%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "15.46%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "50.86%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "A",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "37.78%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "51.60%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "12.70%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "4.41%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "646.73%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "37.78%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.36",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "18.91%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 聯影醫療 (SH.688271) | B | B | C | B | B | B |
| 02 | 魚躍醫療 (SZ.002223) | B | B | C | A | C | B |
| 03 | 惠泰醫療 (SH.688617) | A | B | B | A | B | B |
| 04 | 奕瑞科技 (SH.688301) | A | B | E | A | B | B |
| 05 | 振德醫療 (SH.603301) | C | B | C | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 48.63 | 29/66 | 62.12 | 55.40 | 45.22 |
| PB | 3.14 | 33/66 | 3.01 | 2.72 | 2.39 |
| PS (TTM) | 7.52 | 32/66 | 7.70 | 7.23 | 6.63 |
| Dividend Yield | 0.58% | 35/66 | 1.16% | 0.67% | 0.61% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-06T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 17.26 |
| Highest Target | 16.00 |
| Lowest Target | 16.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/688410.SH/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/688410.SH/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/688410.SH/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.